China hypertension drug sales seen doubling by 2010 – Reuters

From the Reuters:

Sales in China for drugs to treat hypertension are expected to nearly double to more than $800 million by 2010 amid higher awareness of the disease and as more Chinese are exposed to risk factors such as obesity, a U.S. research firm said.

The Chinese market for blood pressure treatment drugs, such as Pfizer Inc.’s Norvasc and Novartis AG’s Diovan, was worth about $440 million last year, roughly 4 percent of the U.S. market, market research firm Decision Resources said in a report released on Tuesday.

Diagnosis rates for hypertension will rise to 41 percent in 2010 from 33 percent last year, boosted by Beijing’s health education efforts, the firm said. [Full Text]

Related article of “Increasing number of Chinese youngsters suffer hypertension” from Xinhua

Another article of “China Adds 3 Million Hypertension Patients a Year” from People’s Daily

Categories :

Tags :

CDT EBOOKS

Subscribe to CDT

SUPPORT CDT

Unbounded by Lantern

Now, you can combat internet censorship in a new way: by toggling the switch below while browsing China Digital Times, you can provide a secure "bridge" for people who want to freely access information. This open-source project is powered by Lantern, know more about this project.

Google Ads 1

Giving Assistant

Google Ads 2

Anti-censorship Tools

Life Without Walls

Click on the image to download Firefly for circumvention

Open popup
X

Welcome back!

CDT is a non-profit media site, and we need your support. Your contribution will help us provide more translations, breaking news, and other content you love.